行业热度还是不高作者：西北哽动辄被摆上“生死线”的CAR-T企业里，突然冒出一个另类：科济药业。3月9日，H股科济药业上涨近30%，不输给今天热门的AI算力概念股迅策。当然，两家公司暴涨的根本原因是纳入港股通。值得一提的是，过去几年“退通”的生物医药企业不少，退了之后又“进通”的却是很少见。科济药业时隔一年重返港股通，市场给予关注也是应有之理。科济药业毕竟是有两把刷子。刚披露的年报显示，2025年...
Source Link行业热度还是不高作者：西北哽动辄被摆上“生死线”的CAR-T企业里，突然冒出一个另类：科济药业。3月9日，H股科济药业上涨近30%，不输给今天热门的AI算力概念股迅策。当然，两家公司暴涨的根本原因是纳入港股通。值得一提的是，过去几年“退通”的生物医药企业不少，退了之后又“进通”的却是很少见。科济药业时隔一年重返港股通，市场给予关注也是应有之理。科济药业毕竟是有两把刷子。刚披露的年报显示，2025年...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.